Genecare Development Limited sold 467,500 shares of TRANSTHERA-B (02617) stock at an average of HKD 12.5786 per share on August 5, 2026, involving about HKD 5.88 million.
Prior to the disposal, Genecare Development Limited's long position in TRANSTHERA-B was 21.96 million shares, representing 7.02%; following the disposal, the holding changed to 21.49 million shares, with the long position ratio falling to 6.87%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments